IV Daratumumab versus Subcutaneous Daratumumab

Saad Usmani, MD, Chief, Plasma Cell Disorders Program, Hematologic Malignancies, Levine Cancer Institute/Atrium Health, UNC Chapel Hill School of Medicine, compares intravenous daratumumab versus subc... Author: obr Added: 07/02/2019
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts